Prostacyclin, thromboxanes, and hematogenous metastasis.
D000818:Animals; D002279:Carcinoma 256, Walker / Q000503:physiopathology*; D002401:Cathepsin B; D002403:Cathepsins / Q000378:metabolism; D011464:Epoprostenol / Q000494:pharmacology / Q000502:physiology*; D005260:Female; D008175:Lung Neoplasms / Q000503:physiopathology*; D008297:Male; D008545:Melanoma / Q000503:physiopathology*; D051379:Mice; D009362:Neoplasm Metastasis / Q000503:physiopathology*; D009374:Neoplasms, Experimental / Q000503:physiopathology; D010974:Platelet Aggregation / Q000187:drug effects; D011453:Prostaglandins / Q000502:physiology*; D011480:Protease Inhibitors / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D013931:Thromboxanes / Q000494:pharmacology / Q000502:physiology*
D011453:Prostaglandins; D011480:Protease Inhibitors; D013931:Thromboxanes; D011464:Epoprostenol; D002403:Cathepsins; D002401:Cathepsin B